Efficacy of IVIg Therapy in Inflammatory Myositis

from 2004 to 2012, affected by polymyositis (PM), dermatomyositis (DM) or inclusion body myositis (IBM) and treated with IVIg. IVIg has been successfully used as rescue therapy in all patients with a periodical dose of 1-2 g/Kg administered in 5 days. The mean follow-up was 37 months. ................
................